We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...

the first American US Open finalist in 18 years and currently ranked #7 in the world by the Association of Tennis Professionals 2. Sinner and Fritz's long-term collaboration with La Roche-Posay ...

Roche is rolling out what it describes as a new type of infectious disease diagnostic in Europe, with a single test capable ...

Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus, cutting down the time needed ...

Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company’s experimental obesity medicine. The poster, released as part ...

Roche Holding AG said it isn’t concerned about side effects in a small study of a weight-loss shot, after details about the trial sent shares tumbling on Monday. “We’re not alarmed at all ...

FRANKFURT, Sept 11 (Reuters) - Roche (ROG.S), opens new tab said on ... of CT-996 in studies of longer duration with larger sample sizes and slower titrations," the company said in a presentation ...

Shares of Roche (OTCQX:RHHBY) slid 5% Wednesday while shares of rivals Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) gained ground after Reuters reported that positive data released by Roche (OTCQX ...